Cystic Fibrosis: A State-of-the-Art Series

1234 E-Mail karger@karger.ch ABC Fax 41 abnormalities Accepted after revision Accessible online activity airway invasion alveolar analysis antibody asbestos associated asthma bacterial BAL fluid BALF Basel baseline biopsy blood bronchial bronchiectasis bronchoalveolar lavage bronchoscopy budesonide cells CFTR chest radiograph cholecystectomy chronic obstructive Clin clinical concentration COPD correlation corticosteroids cystic fibrosis cytokine decrease detected diagnosis dose effects elastase eosinophils epithelial evaluated exposure factors fenoterol FEV1 formoterol gene goblet cell hemoptysis Hospital increased infection inflammation inflammatory inhaled Karger lavage levels lung disease lung function macrophages malignant measured mediastinal ment mesothelioma mutation nCPAP neutrophils normal parameters pleural effusion pleural fluid pleurodesis pneumonia pressure protein pulmonary disease pulmonary function ratio reported Respir Crit Respiration respiratory Rev Respir S.Karger sarcoidosis serum showed significant significantly sleep apnea smoking spirometry sputum steroids subjects symptoms terbutaline therapy Thoracic tion tissue trachea transplantation transudates treatment tumor values